There’s been an impressive amount of healthcare social media coming from the 2012 JP Morgan Healthcare Conference (impressive because, unlike their tech brethren, healthcare investors haven’t taken to social media). The best tidbits are always things overheard in the halls rather than at keynotes. And BioWorld Today has captured some perfect, irony-tinged insight:
Eager consultant overheard @ #JPM12: “We specialize in putting companies in front of the FDA”
2012 prediction: That consultant is going to be busy.
You can follow all the twitter commentary by following #jpm12.
Minimally invasive weight loss device maker quietly raises $2.75 million
Healthcare convergence: When a health plan became a device vendor
5 must-dos for US healthcare reform success, from LinkedIn health groups
Cell cultures in 3-D — Kiyatec raises $2.8M for novel testing platform
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Merrill GooznerPharma, device firms kill conflict of interest rule, win accelerated approval
Dr. John D. HalamkaBYOD makes mobile security more complicated
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Amy SiegelTop 5 anxiety-provoking medtech acronyms
Stephen Schimpff MDIntegrative Medicine Part II — Health Care of the Future
John Mandrola, MDWeighing the risks of Pradaxa vs. the risk of stroke
Comments
Post a comment
No comments yet.
Post a Comment